Lysosomal activable Vorinostat carrier-prodrug self-assembling with BPQDs enables photothermal oncotherapy to reverse tumor thermotolerance and metastasis

International Journal of Pharmaceutics(2022)

Cited 1|Views7
No score
Abstract
•Vorinostat complementing photothermal therapy (PTT) potentiate oncotherapy.•A lysosomal activable nano-complex is fabricated to release drugs spontaneously.•The nano-complex significantly inhibits tumor growth, thermotolerance and metastasis.•Latent mechanism of Vorinostat augmenting PTT has been revealed.•Black phosphorus quantum dots probably down-regulate HSP70 in photothermal therapy.
More
Translated text
Key words
Black phosphorus quantum dots,Photothermal therapy,Histone deacetylase inhibitor,Vorinostat,Thermotolerance,HSP70
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined